Novavax Says Updated COVID-19 Vaccine Now Approved In The EU
Portfolio Pulse from Benzinga Newsdesk
Novavax has received approval from the European Union (EU) for its updated COVID-19 vaccine. The company is now working with EU member states to distribute the vaccine to those who have requested doses through the advance purchase agreement.
October 31, 2023 | 9:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novavax's updated COVID-19 vaccine has been approved by the EU. This approval could potentially increase the company's revenues as it begins distribution in EU member states.
The approval of Novavax's updated COVID-19 vaccine by the EU is a significant milestone for the company. This approval opens up a large market for the company, potentially leading to increased revenues. The company's stock price is likely to react positively to this news in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100